Expression Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Expression Therapeutics's estimated annual revenue is currently $3.4M per year.
- Expression Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Expression Therapeutics has 22 Employees.
- Expression Therapeutics grew their employee count by 0% last year.
Expression Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $1.7M | 11 | -8% | N/A | N/A |
#3 | $2.3M | 15 | 50% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $17.1M | 110 | 5% | $0.07B | N/A |
#6 | $4M | 26 | -7% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $7.8M | 50 | 2% | N/A | N/A |
#10 | $1.7M | 11 | 10% | N/A | N/A |
What Is Expression Therapeutics?
Expression Therapeutics is a biotechnology company based in Atlanta. Our therapeutic pipeline includes advanced gene therapies for hemophilia A and B; neuroblastoma, T-cell leukemia/lymphoma, and acute myeloid leukemia (AML); and hematologic disorders such as hemophagocytic lymphohistiocytosis (HLH). Each product candidate has been specifically engineered using proprietary gene expression biotechnologies designed for optimal safety and efficacy. Our mission is to develop novel gene therapies that will dramatically improve the lives of patients.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Atlanta
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.9M | 22 | 10% | N/A |
#2 | $2.2M | 22 | N/A | N/A |
#3 | $3.2M | 22 | N/A | N/A |
#4 | $2.2M | 22 | N/A | N/A |
#5 | $2.2M | 22 | N/A | N/A |